Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma

Medical Oncology

Volumn 31, Issue 7, 2014, Pages

  Wang, Jun Li ^a   Nong, Le Gen ^a   Tang, Yu Jin ^a   Wei, Ye Sheng ^a   Yang, Feng Lian ^a   Wang, Chun Fang ^a  

^a YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

Author keywords

Genotype; Nasopharyngeal carcinoma; Osteopontin; Polymorphism

Indexed keywords

OSTEOPONTIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; NASOPHARYNX TUMOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84901876218     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0020-x     Document Type: Article

References (16)

1. Furger KA, Menon RK, Tuck AB, Bramwell VH, Chambers AF. The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med. 2001;1:621-32. (Pubitemid 33772040)
2. Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta. 2001;552:61-85. (Pubitemid 34124131)
3. Yeatman TJ, Chambers AF. Osteopontin and colon cancer progression. Clin Exp Metastasis. 2003;20(1):85-90. (Pubitemid 36308140)
4. Rohde F, Rimkus C, Friederichs J, et al. Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer. Int J Cancer. 2007;121(8):1717-23. (Pubitemid 47417288)
5. Wong KK, Cheng RS, Mok SC. Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system. Biotechniques. 2001;30:670-5. (Pubitemid 32202873)
6. Kim J-H, Skates SJ, Uede T, et al. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA. 2002;287:1671-9. (Pubitemid 34289219)
7. Wong TS, Kwong DL, Sham J, et al. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma. Eur J Surg Oncol. 2005;31(5):555-8. (Pubitemid 40724099)
8. Wang HH, Wang XW, Tang CE. Osteopontin expression in nasopharyngeal carcinoma: its relevance to the clinical stage of the disease. J Cancer Res Ther. 2011;7(2):138-42.
9. Lee JL, Wang MJ, Sudhir PR, Chen GD, Chi CW, Chen JY. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44v interaction enhances survival in gastrointestinal cancer cells. Cancer Res. 2007;67:2089-97.
10. Marciano R, Giacopelli F, Divizia MT, Gattorno M, Felici E, Pistorio A, Martini A, Ravazzolo R, Picco P. A polymorphism variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis. Ann Rheum Dis. 2006;65:662-5.
11. Gao B, Yasui T, Itoh Y, Li Z, Okada A, Tozawa K, Hayashi Y, Kohri K. Association of osteopontin gene haplotypes with nephrolithiasis. Kidney Int. 2007;72:592-8. (Pubitemid 47312789)
12. Mochida S, Hashimoto M, Matsui A, Naito M, Ihao M, Nagoshi S, Nagano M, Egashira T, Mishiro S, Fuiiwara K. Genetic polymorphisms in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients. Biochem Biophys Res Commun. 2004;313:1079-85.
13. Chang YS, Kim HJ, Chang J, Ahn CM, Kim SK, Kim SK. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Lung Cancer. 2007;57:373-80. (Pubitemid 47285428)
14. Shin HD, Park BL, Cheong HS, Yoon JH, Kim YJ, Lee HS. SPP1 polymorphisms associated with HBV clearance and HCC occurrence. Int J Epidemiol. 2007;36:1001-8. (Pubitemid 350018544)
15. Caillier S, Barcellos LF, Baranzini SE, et al. Osteopontin polymorphisms and disease course in multiple sclerosis [J]. Genes Immun. 2003;4:312-5. (Pubitemid 39562131)
16. Forton AC, Petri MA, Goldman D, Sullivan KE. An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat. 2002;19:459-62.